TABLE 3.

Variety of adverse events in each regimen.

Variables	HT group	BQT group	p-value
Total	8 (10.6)	20 (26.6)	0.026
Adverse events grades
Mild	6	16
Moderate	2	4
Severe	0	0
Adverse events
Nausea	4	9
Vomiting	1	2
Abdominal pain	1	1
Bloating	0	2
Diarrhea	2	6
Skin rash	0	0
Poor compliance	1	2	0.977

Abbreviations: HT, high‐dose dual therapy; BQT, bismuth quadruple therapy.